Peptide analogues alter the progression of premalignant lesions, as measured by Photofrin fluorescence.

Somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 were infused at 2 micrograms per day via miniosmotic pumps implanted s.c. in hamsters with premalignant disease to examine the effect of these peptides on cancer promotion and progression. These analogues have bee...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Liebow, C, Crean, D H, Schally, A V, Mang, T S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC45987/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8095335/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.90.5.1897
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!